ACR Convergence 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences

IU

Istanbul University-Cerrahpaşa at ACR Convergence 2026

Nov 6–11, 2026 Orlando, FL ~15k attendees Website

Istanbul University-Cerrahpaşa brings 7 presentations to ACR Convergence 2026 in Orlando. Its program centres on familial Mediterranean fever, including new IL-1 blocking treatment, anakinra, colchicine formulations and long-term survival. It also covers Behçet's syndrome, from diagnostic skin testing to its neurological form and management.

OrganizationACR Convergence 2026 Attendance
IU
Istanbul University-Cerrahpaşa
Istanbul, Turkey
Universities and research institutes
A public university in Istanbul.
Talk
Wed Nov 11
8:00am–8:30am
Part of Behçet Syndrome: Updates in Pathogenesis, Diagnosis, and Management
Management of Behçet Syndrome: Evidence, Experience, and Evolving Practice
W415A
Vasculitis
Talk
Wed Nov 11
8:30am–9:00am
Part of Behçet Syndrome: Updates in Pathogenesis, Diagnosis, and Management
Expanding Spectrum and Mimickers of Neuro-Behçet's
W415A
Vasculitis

Explore the full ACR Convergence 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Orlando. Leave your work email and we’ll be in touch.

Privacy

Download the full ACR Convergence 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Istanbul University-Cerrahpaşa

Tell us what you sell and we’ll find the people at Istanbul University-Cerrahpaşa most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the American College of Rheumatology (ACR). Organization details are derived from the ACR’s published program and exhibitor floor plan, and each organization’s own website. Submit a correction